BlueWhale Bio, co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy and James Riley, PhD, Professor of Microbiology, both at Penn Medicine, will utilize the funding and their partnership with the life sciences tools company to accelerate the scale-up and production of BlueWhale’s Synecta™ CDNP platform enabling efficient CAR T-cell manufacturing. Learn more here.